US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
U.S. drug company Merck to share license for experimental covid-19 treatment with non-profit
US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
More Stories
How the World’s Top 10 Cities Are Ringing In the New Year
Puerto Rico Power Grid Fails on NYE
What Happened to the Stock Markets Dec. 23rd? Sources Claim Over 70 Billion in FTD’s